{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:54:27Z","timestamp":1766451267049,"version":"3.37.3"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","award":["Robert Wenner Award"],"award-info":[{"award-number":["Robert Wenner Award"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189309","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T18:34:37Z","timestamp":1513017277000},"page":"e0189309","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-2875","authenticated-orcid":true,"given":"Eliane","family":"Rohner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Grabik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomy","family":"Tonia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"P\u00e9tavy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pignatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1955-1585","authenticated-orcid":true,"given":"Julia","family":"Bohlius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jama.290.4.495","article-title":"Factors associated with failure to publish large randomized trials presented at an oncology meeting","volume":"290","author":"MK Krzyzanowska","year":"2003","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"EH Turner","year":"2008","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"JJ Kirkham","year":"2010","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm0912-1321","article-title":"(Meta)analyze this: Systematic reviews might lose credibility","volume":"18","author":"P Humaidan","year":"2012","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e1002127","DOI":"10.1371\/journal.pmed.1002127","article-title":"Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review","volume":"13","author":"S Golder","year":"2016","journal-title":"PLOS Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.1986.4.10.1529","article-title":"Publication bias: the case for an international registry of clinical trials","volume":"4","author":"RJ Simes","year":"1986","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"e0178379","DOI":"10.1371\/journal.pone.0178379","article-title":"Evidence of selective reporting bias in hematology journals: A systematic review","volume":"12","author":"C Wayant","year":"2017","journal-title":"PLoS One"},{"key":"ref8","first-page":"w13776","article-title":"Cancer, meta-analysis and reporting biases: the case of erythropoiesis-stimulating agents","volume":"143","author":"T Tonia","year":"2013","journal-title":"Swiss Med Wkly"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejca.2016.03.066","article-title":"Bias in reporting of randomised clinical trials in oncology","volume":"61","author":"FE Vera-Badillo","year":"2016","journal-title":"Eur J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e1001526","DOI":"10.1371\/journal.pmed.1001526","article-title":"Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data","volume":"10","author":"B Wieseler","year":"2013","journal-title":"PLoS Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"g3510","DOI":"10.1136\/bmj.g3510","article-title":"Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications","volume":"348","author":"E Maund","year":"2014","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(04)16043-1","article-title":"Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data","volume":"363","author":"CJ Whittington","year":"2004","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"c4737","DOI":"10.1136\/bmj.c4737","article-title":"Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials","volume":"341","author":"D Eyding","year":"2010","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bmj.326.7400.1171","article-title":"Evidence b(i)ased medicine\u2014selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications","volume":"326","author":"H Melander","year":"2003","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e8001","DOI":"10.1136\/bmj.e8001","article-title":"We need access to data on all clinical trials, not just some","volume":"345","author":"B Wieseler","year":"2012","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMp1409464","article-title":"Transparency and the European Medicines Agency\u2014sharing of clinical trial data","volume":"371","author":"S Bonini","year":"2014","journal-title":"N Engl J Med"},{"key":"ref17","first-page":"CD003407","article-title":"Erythropoietin or darbepoetin for patients with cancer","volume":"12","author":"T Tonia","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","first-page":"CD003407","article-title":"Erythropoietin for patients with malignant disease","volume":"3","author":"J Bohlius","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","first-page":"CD003407","article-title":"Erythropoietin or Darbepoetin for patients with cancer","volume":"3","author":"J Bohlius","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"ref20","first-page":"CD007303","article-title":"Erythropoietin or Darbepoetin for patients with cancer\u2014meta-analysis based on individual patient data","volume":"3","author":"J Bohlius","year":"2009","journal-title":"Cochrane Database Sys Rev"},{"article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","year":"2011","author":"JPT Higgins","key":"ref21"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0885-3924(02)00529-8","article-title":"Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales","volume":"24","author":"D Cella","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/bjc.2014.171","article-title":"Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data","volume":"111","author":"J Bohlius","year":"2014","journal-title":"Br J Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/S0140-6736(09)60502-X","article-title":"Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials","volume":"373","author":"J Bohlius","year":"2009","journal-title":"Lancet (London, England)"},{"key":"ref25","unstructured":"MF4362. Open-label, randomized phase III study to investigate the effect of epoetin beta on blood transfusion need in children with various malignant solid tumours treated with chemotherapy. 2006."},{"key":"ref26","unstructured":"XM01-23. Efficacy and safety of XM01 compared to placebo in anaemic patients with low grade non-Hodgkin\u2019s lymphoma, chronic lymphocytic leukaemia or multiple myeloma receiving anticancer therapy. 2008."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/annonc\/mdq713","article-title":"PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin\u2013cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer\u2014outcome on prognosis","volume":"22","author":"M Untch","year":"2011","journal-title":"Ann Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1525-1438.2007.01032.x","article-title":"Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer","volume":"18","author":"H-G Strauss","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1753-5174.2010.00030.x","article-title":"Epoetin Theta in Anaemic Cancer Patients Receiving Platinum-Based Chemotherapy: A Randomised Controlled Trial","volume":"3","author":"SA Tjulandin","year":"2010","journal-title":"Arch Drug Inf"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1753-5174.2011.00035.x","article-title":"Epoetin Theta with a New Dosing Schedule in Anaemic Cancer Patients Receiving Nonplatinum-Based Chemotherapy: A Randomised Controlled Trial","volume":"4","author":"SA Tjulandin","year":"2011","journal-title":"Arch Drug Inf"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.2002.08.131","article-title":"Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic Malignancies","volume":"20","author":"A \u00d6sterborg","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood.V86.12.4446.bloodjournal86124446","article-title":"Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin\u2019s lymphoma: dose finding and identification of predictors of response","volume":"86","author":"M Cazzola","year":"1995","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial","volume":"362","author":"M Henke","year":"2003","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/annonc\/mdt505","article-title":"Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer\u2020","volume":"25","author":"U Nitz","year":"2014","journal-title":"Ann Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.2007.14.2885","article-title":"Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study","volume":"26","author":"RE Smith","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1008296622469","article-title":"Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study","volume":"9","author":"C Oberhoff","year":"1998","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1503\/cmaj.090470","article-title":"Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis","volume":"180","author":"M Tonelli","year":"2009","journal-title":"CMAJ"},{"key":"ref38","first-page":"CD006704","article-title":"Drug therapy for the management of cancer-related fatigue","volume":"7","author":"O Minton","year":"2010","journal-title":"Cochrane Database Sys Rev"},{"key":"ref39","article-title":"Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment","author":"MD Grant","year":"2013","journal-title":"Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update. Agency for Healthcare Research and Quality (US)"},{"key":"ref40","first-page":"CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children","volume":"4","author":"T Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jama.2017.0918","article-title":"The European Medicines Agency and Publication of Clinical Study Reports: A Challenge for the US FDA","volume":"317","author":"AL Davis","year":"2017","journal-title":"JAMA"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T04:30:21Z","timestamp":1603513821000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189309"}},"subtitle":[],"editor":[{"given":"Robert S.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189309","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,12,11]]}}}